发明授权
- 专利标题： Heterocyclic compounds and methods of use
- 专利标题（中）： 杂环化合物和使用方法
-
申请号： US12641141申请日： 2009-12-17
-
公开(公告)号： US08232273B2公开(公告)日： 2012-07-31
- 发明人: Jonathan Bayldon Baell , Chinh Thien Bui , Peter Colman , Peter Czabotar , Danette A. Dudley , Wayne J. Fairbrother , John A. Flygare , Guillaume Laurent Lessene , Chudi Ndubaku , George Nikolakopoulos , Brad Edmund Sleebs , Brian John Smith , Keith Geoffrey Watson , Steven W. Elmore , Lisa A. Hasvold , Andrew M. Petros , Andrew J. Souers , Zhi-Fu Tao , Le Wang , Xilu Wang , Kurt Deshayes
- 申请人： Jonathan Bayldon Baell , Chinh Thien Bui , Peter Colman , Peter Czabotar , Danette A. Dudley , Wayne J. Fairbrother , John A. Flygare , Guillaume Laurent Lessene , Chudi Ndubaku , George Nikolakopoulos , Brad Edmund Sleebs , Brian John Smith , Keith Geoffrey Watson , Steven W. Elmore , Lisa A. Hasvold , Andrew M. Petros , Andrew J. Souers , Zhi-Fu Tao , Le Wang , Xilu Wang , Kurt Deshayes
- 申请人地址： US CA South San Francisco US IL Abbott Park AU Victoria
- 专利权人： Genentech, Inc.,Abbott Laboratories,The Walter and Eliza Hall Institute of Medical Research
- 当前专利权人： Genentech, Inc.,Abbott Laboratories,The Walter and Eliza Hall Institute of Medical Research
- 当前专利权人地址： US CA South San Francisco US IL Abbott Park AU Victoria
- 代理机构： Jones Day
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; C07D413/14
摘要：
In one aspect, the present invention provides for a compound of Formula I in which the variable X1a, X1b, X1c, X1d, Q, A, R1, B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-xL proteins.
公开/授权文献
- US20100210622A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE 公开/授权日：2010-08-19
信息查询
IPC分类:
